Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...

Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...

An expert in gout clinical trials questions whether ethical considerations for such trials need updating to emphasize patient ...

This came after the drug major Sun Pharma Laboratories presented the proposal to conduct Phase III clinical trial titled “A ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

The intervention being tested is the drug Etelcalcetide, which is administered intravenously. It is designed to manage secondary hyperparathyroidism by controlling levels of intact parathyroid hormone ...

Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of RezdiffraPoster of ...

About ORLADEYO ® (berotralstat) ORLADEYO ® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 ...

Application based on positive results from Phase 3 PEGASUS study, which demonstrated statistically significant blood phenylalanine (Phe) lowering compared to diet ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. How Long Does It Take for Wegovy® To Work? When considering ...

Ooops... Something went wrong while loading this page.

BioMarin Pharmaceutical Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the company's PALYNZIQ® (pegvaliase-pqpz) supplemental Biologics License ...